Skip to content
Screener

Beta Bionics BBNX Asset turnover

Asset turnover at other companies

Insulet logo
InsuletPODD
0.9×+0.2×
Tandem Diabetes Care logo
Tandem Diabetes CareTNDM
1×-0.1×
Medtronic logo
MedtronicMDT
0.4×0.0×
Embecta Corp. logo
Embecta Corp.EMBC
0.8×-0.1×
AdaptHealth logo
AdaptHealthAHCO
0.7×0.0×
Halozyme Therapeutics logo
Halozyme TherapeuticsHALO
0.7×+0.1×

Other financials

Income statement

See full
Revenue$32.0M+37.8%
Gross profit$18.9M+51.2%
Operating income-$25.6M-28.7%
Net income-$23.4M-38.7%
EPS (diluted)-$0.53-35.9%

Balance sheet

See full
Cash & equivalents$44.3M+26.4%
Total debt$6.5M-2.6%
Total equity$256.4M-15.0%
Total assets$292.4M-11.4%

Cash flow

See full
Operating cash flow-$14.6M-7.6%
CapEx$1.0M-41.6%
Free cash flow-$15.7M-1.9%

Valuation

See full
Market cap$715.34M+15.1%
Enterprise value$677.53M+14.2%
P/S6×-2.0×

Profitability

See full
Gross margin58.3%+4.4pp
Operating margin-69.8%-8.0pp
Net margin-61.3%-15.8pp
FCF margin-51.6%-13.4pp

Returns & leverage

See full
Return on equity-26.2%—
Debt / equity0×0.0×
Current ratio8.9×-5.8×

Where this comes from

Calculated from Beta Bionics’s reported figures.

total revenue/total assets=0.4×

Based on trailing twelve months.

The source filing: Beta Bionics’s 10-Q, filed July 29, 2026. Open the filing →

Filed
Jul 29, 2026, 4:20 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-323777

FAQ

What is Beta Bionics's asset turnover?
Beta Bionics (BBNX) reported asset turnover of 0.4× in Q2 2026.
What does asset turnover mean?
Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.

Ask your AI about Beta Bionics's asset turnover.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude